AzTrials
AzTrials

Low Back PainNCT05079893

Influence of Kinesiophobia on the Outcome of Chronic Low Back Pain Condition

An observational study of Low Back Pain, run by Gulf Medical University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Though large body of evidence reported association between pain and kinesiophobia, there are paucity of studies in associating kinesiophobia to muscle endurance and position sense in patients with Chronic lower back pain [CLBP]. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Low Back Pain
How many people
600 participants
Where
No sites listed yet
Study dates
15 Oct 2021to 31 Jan 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Adult

Study population: Suffering from low back pain for at least three months and referred by an orthopedic doctor or general physician.

Who may be able to join

  • Adults aged between 18 and 50 years.
  • Suffering from low back pain for at least three months and referred by an orthopedic doctor or general physician.
  • Enough physical autonomy to participate in the physical activities required by the study.

Who cannot join

  • Low back pain patients with radiculopathy, post fractures, stenosis and history of tumors, cauda equina syndrome and infection.
  • Patient under antidepressive medication Inclusion Criteria for Asymptomatic subjects Age 18 years and above, Either gender.
  • H/o previous lower back injury.
  • H/o lower limb or trunk pathology.
  • Presence of deformity, or condition that may alter motor control.
  • History of inflammatory, infectious disease and malignancy in the spine
  • Patient under anti depressive medication

Trial locations and contacts

No sites are listed yet.

Dr. Praveen Kumar Kandakurthi, PhD contact

+971 6 7431333 ext. 1386

dean.coahs@gmu.ac.ae

About this study

Official title: Influence of Kinesiophobia on Pain Intensity, Disability, Muscle Endurance and Position Sense in Subjects With Chronic Low Back Pain- A Case Control Study

Though large body of evidence reported association between pain and kinesiophobia, there are paucity of studies in associating kinesiophobia to muscle endurance and position sense in patients with Chronic lower back pain [CLBP]. To the best of Investigator's knowledge, till date there is no studies assessing the relationship between kinesiophobia and endurance and position sense in subjects with CLBP. Therefore, the current study aims to compare the impact of kinesiophobia on lumbar extensor endurance, position sense in patient with CLBP and asymptomatic individuals.

Read the detailed description

Background:

Patients with chronic low back pain (CLBP) frequently present with kinesiophobia. Recent high quality studies reported a moderate to strong evidence of associations between a greater degree of kinesiophobia and greater levels of pain, greater levels of disability and poorer quality of life. However, there are paucity of studies in associating kinesiophobia to muscle endurance and position sense in patients with CLBP.

Objective:

The primary aim of the study is to compare the impact of kinesiophobia on lumbar extensor endurance, position sense in patient with CLBP and asymptomatic individuals. Secondarily, to examine the association between kinesiophobia and lumbar extensor endurance, position sense, pain intensity and functional ability in patients with CLBP. Thirdly to assess the degree of association with various factors on CLBP, lumbar endurance and position sense.

Material and Methods:

This case-control study will have 200 patients with CLBP and 400 controls. Kinesiophobia will be assessed with Tampa Scale for Kinesiophobia. Lumbar endurance will be assessed with Soren's lumbar extensor test and lumbar position sense with neutral and target lumbar re-positioning tests. Secondarily, the pain intensity will be assessed with visual analog scale, functional ability with patient-specific Functional Scale in patients with CLBP. Kinesiophobia, lumbar endurance, and joint position sense will be compared between patients and controls. Kinesiophobia scores will be correlated with lumbar extensor endurance and proprioception joint position errors, pain intensity, and functional ability. Simple and multiple binary logistic regression will be used to determine crude and adjusted Odd's Ratio for kinesiophobia, lumbar position sense and kinesiophobia, lumbar endurance.

Conditions
Low Back Pain
Being tested
Case control study
Keywords
Low back pain, Kinesiophobia, position sense, Endurance
Medical subject headings
Low Back Pain, Kinesiophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Case control studyOther

    Observational case control study

Study groups in NCT05079893
Study groupRoleWhat they receive
CasesThe cases will be the patients suffering from low back pain for at least three months and referred by an orthopedic doctor or general physician.
Receives: Other: Case control study
ControlsThe controls will be the patients matched for age, sex, handedness who had no complaints of lower back pain
Receives: Other: Case control study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measuring Kinesiophobia.

    Fear of movement/injury or reinjury will be assessed using the Tampa Scale for Kinesiophobia (TSK), a 17 self-reporting items with scores ranging from 17 (absence of fear) to 68 (highest fear). Tampa Scale for Kinesiophobia has been reported to have good reliability in patients with CLBP.

    Measured: 5 MONTHS

  2. Measuring Lumbar extensor endurance.

    The subjects will be tested during a 1-hour session and will be asked to undergo a body weight dependent isometric back extension (Sorensen) test on a horizontal table

    Measured: 5 MONTHS

  3. Measuring Lumbar repositioning tests

    Lumbar repositioning tests will be measured with dual inclinometer

    Measured: 5 MONTHS

Secondary outcomes (2)
  1. Measuring Pain

    measured with Visual analog scale (VAS). The visual analogue scale consists of a 10-cm line, with the left extremity representing (absence of pain) and the right extremity indicating (great pain). Participants were asked to indicate in the scale their current level of pain, higher values being related to more intense pain.

    Measured: 5 MONTHS

  2. Measuring Functional ability

    Functional ability will be measured using Patient-specific Functional Scale. Patients are asked to rate (on an 11-point scale) the current level of difficulty associated with each activity, where "0" represents "unable to perform" and "10" represents "able to perform at prior level

    Measured: 5 MONTHS

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2021
  2. Study start15 Oct 2021 (estimated)
  3. Primary completionJan 2022 (estimated)
  4. Study completion31 Jan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05079893
Sponsor's protocol ID
IRB/COHS/FAC/03/May-2021
Status last verified
Oct 2021
First submitted
23 Sep 2021
Last updated
15 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kandakurti PK, de Sa Ferreira A, Calazans Nogueira LA, Arulsingh Daniel Ragland W, Patil SS. Influence of kinesiophobia on lumbar position sense in patients with chronic low back pain-a case-control study. J Back Musculoskelet Rehabil. 2025 Sep;38(5):1158-1164. doi: 10.1177/10538127251326152. Epub 2025 Mar 20.

    PubMed 40111910
  • Kandakurti PK, Arulsingh W, S Patil S. Influence of kinesiophobia on pain intensity, disability, muscle endurance, and position sense in patients with chronic low back pain-a case-control study. Trials. 2022 Jun 6;23(1):469. doi: 10.1186/s13063-022-06406-6.

    PubMed 35668498

Questions about this trial

What is this clinical trial studying?

An observational study of Low Back Pain, run by Gulf Medical University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dr. Praveen Kumar Kandakurthi, PhD (+971 6 7431333 ext. 1386, dean.coahs@gmu.ac.ae), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measuring Kinesiophobia. (time frame: 5 MONTHS). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05079893, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2021; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in